Blue Heron Biotechnology provides a range of synthetic DNA sequences and related services to researchers and biotechnology companies.
Blue Heron Biotechnology has been a pioneer and leader of the gene synthesis market since its founding in 1999. Blue Heron provides the broadest range of synthetic DNA sequences and related services to thousands of researchers across multiple industries, including 19 of the top 20 pharmaceutical and biotechnology companies.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Jan 16, 2007 | Series D | $3.68M | 1 | — | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
Crabtree Ventures | — | Series D |